pregnenolone carbonitrile has been researched along with transforming growth factor beta in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Klaassen, CD; Kolaja, KL | 1 |
Hood, AM; Klaassen, CD; Kolaja, KL | 1 |
Beyer, C; Dees, C; Distler, A; Distler, JH; Distler, O; Leipe, J; Munoz, L; Reichert, H; Schett, G; Schulze-Koops, H; Skapenko, A | 1 |
3 other study(ies) available for pregnenolone carbonitrile and transforming growth factor beta
Article | Year |
---|---|
Dose-response examination of UDP-glucuronosyltransferase inducers and their ability to increase both TGF-beta expression and thyroid follicular cell apoptosis.
Topics: Animals; Apoptosis; Chlorodiphenyl (54% Chlorine); Dose-Response Relationship, Drug; Enzyme Induction; Glucuronosyltransferase; Immunohistochemistry; Male; Methylcholanthrene; Phenobarbital; Pregnenolone Carbonitrile; Rats; Rats, Sprague-Dawley; Thyroid Gland; Transforming Growth Factor beta | 1998 |
The UDP-glucuronyltransferase inducers, phenobarbital and pregnenolone-16alpha-carbonitrile, enhance thyroid-follicular cell apoptosis: association with TGF-beta1 expression.
Topics: Animals; Apoptosis; Enzyme Induction; Glucuronosyltransferase; Hyperplasia; Male; Phenobarbital; Pregnenolone Carbonitrile; Rats; Rats, Sprague-Dawley; Thyroid Gland; Transforming Growth Factor beta | 1999 |
Activation of pregnane X receptor inhibits experimental dermal fibrosis.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; CD4-Positive T-Lymphocytes; Cells, Cultured; Dermis; Disease Models, Animal; Fibroblasts; Fibrosis; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Pregnane X Receptor; Pregnenolone Carbonitrile; Receptors, Steroid; Scleroderma, Systemic; Signal Transduction; Transforming Growth Factor beta | 2013 |